Preterm Infants on Early Solid Foods

Infant, Very Low Birth Weight Clinical Trial

— PIES-Project  

Official title:

Early Introduction of Solid Foods in Preterm Infants: Effects on Growth, Atopy and Neurodevelopment

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT01809548
• Other study ID #: PIES001
• Status: Active, not recruiting
• Phase: N/A
• Start date: October 2013
• Est. completion date: December 2024

Study information

• Verified date: April 2022
• Source: Medical University of Vienna
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Introduction: Preterm infants with a birth weight less than 1500 grams have special nutritional needs in comparison to full-term neonates. During their stay in the neonatal intensive care unit an increased supply with energy, protein and electrolytes is necessary to establish adequate growth. After discharge from the hospital special breast milk supplements or post discharge formulas are available to cover the special nutrient requirements. Complementary feeding in preterm infants is an unexplored field so far and nutritional concepts for the first year of life are not available. Data concerning the optimal time for starting solid foods are missing as well as information concerning the ideal composition of complementary food. In this context it is essential to meet the special nutritional needs of "Ex-Preemies" on the one hand and avoid overfeeding and later obesity on the other hand. So far it remains unclear, what the "safe" time point for introduction of solid food to premature infants is and whether this time point influences growth, body composition, neurodevelopmental outcome or the incidence of atopic disease.

Description:

Aim: In a prospective, randomized, two arm intervention study- the PIES project- we aim to investigate the impact of different time points of introduction of complementary food on growth, body composition, atopic disease and neurodevelopmental outcome in preterm infant with a birth weight <1500 grams. Furthermore, we want to investigate whether a certain standardized feeding protocol meets the nutritional needs of premature infants, and obtain data on safety and efficacy in this context. Methods: At term infants are stratified according to breastfed or formula fed and randomized in one of the following groups: an EARLY complementary feeding group (introduction of complementary food between the 10th and 12th week of life corrected for term, n=76) and LATE complementary feeding group (introduction of complementary food between the 16th and 18th week of life corrected for term, n=76). The infants will be fed with standardized complementary food in addition to formula or breastfeeding until they are one year corrected for prematurity. In an age dependent step up concept, food boxes are delivered to the parents: five types of standardized food boxes with manifold complementary food according to the infants' age and the ability to tolerate small pieces are available for each child during the study. The standardized complementary feeding regimen allows calculating exact intake of nutrients and therefore will provide information concerning primary and secondary outcome. The follow up phase will last until 5 years of age. Within regular visits anthropometric data (height, head circumference, weight, BMI and z-scores ) and body composition via the PeaPod® system will be gathered. Data on atopy will be assessed by clinical scoring system SCORAD (SCORing Atopic Dermatitis) and the laboratory parameters Fx5(Fx5 test uses six food allergens: wheat, egg, cow's milk, soya, peanut and fish) and IgE (immuneglobulineE). Neurodevelopmental outcome will be assessed at the age of one and two years corrected for term by the Bayley Scales and the K-ABC (Kaufman Assessment Battery for Children). The nutritional concept will be monitored concerning short term safety and efficacy (bone metabolism, iron status, protein- and lipid status) as well as regarding long term outcome (diabetes and obesity markers IGF-1 (Insulin-like growth factor-1, adiponectin and leptin).

With the PIES project we intend to close a gap of knowledge in feeding the premature infant during the first year of life and to understand the impact of complementary feeding on growth, atopy, neurodevelopmental outcome and later obesity.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 177
• Est. completion date: December 2024
• Est. primary completion date: March 30, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A to 3 Months

Eligibility

Inclusion Criteria:

• Preterm infants <1500 gram

• Informed consent

Exclusion Criteria:

Diseases affecting stable growth:

• Gastrointestinal diseases: necrotizing enterocolitis, Hirschsprung disease, chronic inflammatory bowel disease

• Bronchopulmonary dysplasia (BPD) defined as oxygen demand above 36 week gestational age

• Congenital heart diseases

• major congenital birth defects

• chromosomal aberrations

Related Conditions & MeSH terms

• Birth Weight
• Failure to Thrive
• Growth Failure
• Infant, Very Low Birth Weight

Intervention

Other:
• Early intervention group
solid food will be introduced between week 10 and 12
• Late intervention group
solid food is introduced between 16-18th week of gestation corrected for prematurity

Locations

Country	Name	City	State
Austria	Medical University of Vienna	Vienna

Sponsors (1)

Lead Sponsor	Collaborator
Medical University of Vienna

Country where clinical trial is conducted

Austria, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Height:	To investigate whether a height difference of 5% at one year of age, corrected for prematurity, can be achieved between the early and the late intervention group.; Height will be measured under standardized conditions in centimeter (cm) at defined times during the first year of life until one year of age corrected for prematurity. Measurements will be done before, within and after intervention in order to demonstrate the changes due to all intervention tools.	1 Year
Secondary	neurodevelopmental outcome	To achieve an improvement of neurodevelopmental outcome assessed by Bayley scales and the K-ABC	5 years
Secondary	IGF-1	To evaluate the risk for later obesity	5 years
Secondary	FX5	To achieve a reduction in risk for atopic diseases	5 years
Secondary	SCORAD	To achieve a reduction in risk for atopic diseases.	5 years
Secondary	Body composition	To achieve an increase of free fat mass (FFM) in body composition measured with the Peapod.	5 years
Secondary	Vitamin D	To achieve a degree of bone mineralization.	1 year
Secondary	Iron status	To achieve the development of anemia	1 year
Secondary	Leptin	To evaluate the risk for later obesity	5 years
Secondary	BMI	to evaluate anthropometric parameters	5 years
Secondary	weight	to evaluate anthropometric parameters	5 years
Secondary	head circumference	to evaluate anthropometric parameters	5 years
Secondary	z-scores	to evaluate anthropometric parameters	5 years